Hospital Bed denied as experimental or investigational by Cigna?

Cigna's specific coverage criteria for hospital bed are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Deny a Home Hospital Bed as Experimental

An experimental or investigational denial for a home hospital bed is less common than other denial types but does occur — typically when a specific feature, configuration, or accessory being requested (such as a specialty pressure-relief surface, an advanced positioning system, or an integrated monitoring component) is characterized as lacking sufficient evidence for coverage under Cigna's criteria. Standard manual and semi-electric hospital beds are well-established DME; however, add-on features or newer configurations may trigger experimental review.

These denials are appealable, particularly when the ordering physician can document that the requested feature is clinically necessary, recognized in applicable clinical guidelines (such as those from wound care or rehabilitation societies), and not merely for patient convenience.

## Your Federal Appeal Rights

ACA Section 2719 requires internal appeal and independent external review for non-grandfathered plans. ERISA Section 503 governs employer-sponsored plans. You generally have approximately four months from the final internal denial to request external review through Cigna's designated independent review organization (IRO). Expedited review is available when the patient's condition is urgent.

## Appeal Process and Timeline

1. Identify exactly what was denied as experimental — is it the bed itself, a specific feature, or an accessory? The denial letter must specify. 2. Request the clinical criteria Cigna applied to classify the item as experimental. 3. Ask the ordering physician to request a peer-to-peer review with Cigna's medical director — particularly effective for DME experimental denials. 4. File a written internal appeal by the deadline on the EOB. 5. Request external review if the internal appeal fails.

## Documentation to Gather

• Physician's order and certificate of medical necessity: Specifically addressing the clinical need for the feature or configuration characterized as experimental.
• Clinical notes and specialist assessments: Documentation from the treating physician, physical therapist, or occupational therapist describing the patient's condition and why standard equipment is insufficient.
• Applicable clinical guideline references: Identify the professional organization (e.g., relevant wound care, rehabilitation, or long-term care society) whose guideline supports the equipment feature — the appeal letter should name the organization.
• Functional assessment: A written evaluation describing the patient's deficits and the specific equipment characteristics required to address them safely.
• Prior equipment failure documentation: If standard equipment was tried and was insufficient, document that with dates and clinical outcomes.

## Criteria-Mapping Structure

Obtain Cigna's definition of "experimental" from their DME coverage policy. Build a point-by-point rebuttal:

| Cigna's Experimental Classification Element | Rebuttal Evidence | |---|---| | No peer-reviewed clinical evidence for the feature | Applicable guideline organization supporting the feature | | Not recognized as standard of care | Physician letter citing clinical practice norms | | No functional superiority over covered alternative | Functional assessment comparing outcomes | | Clinical necessity not established | Certificate of medical necessity with diagnosis detail |

Ensure the certificate of medical necessity is individualized to this patient's clinical presentation — generic certificates are the most frequent reason DME experimental-denial appeals fail at the internal stage.